Penatalaksanaan Gagal Napas pada Poliautoimun Multipel Sklerosis dengan Krisis Miastenia
DOI:
https://doi.org/10.36452/jkdoktmeditek.v31i6.4000Keywords:
autoimmune diseases, early mobilization, myasthenia gravis, pulmonary rehabilitation, ventilator-associated pneumoniaAbstract
Introduction: Polyautoimmune involving multiple sclerosis (MS) and myasthenia gravis (MG) is rare, with overlapping clinical manifestations due to shared immunopathogenic mechanisms. The main challenge in such patients is the high risk of ventilator weaning failure, especially when complicated by ventilator-associated pneumonia (VAP). This report highlights the rarely reported success of ventilator weaning through a multidisciplinary and comprehensive management approach in MS-MG polyautoimmunity. Case Illustration: A 39-year-old female with relapsing-remitting MS and MG developed a myasthenic crisis requiring mechanical ventilation. Therapeutic plasma exchange (TPE) was initiated on the second day of treatment and continued for five cycles. Ventilator weaning was performed gradually in accordance with clinical improvement, but was hindered by VAP, necessitating tracheostomy. High-protein enteral nutrition support and early mobilization were initiated on the second day of treatment. After 24 days of intensive care, the patient was successfully weaned from the ventilator with stable respiratory function and improved muscle strength. She was discharged ten days later with tracheostomy care instructions and was able to perform independent active mobilization. Discussion: MS-MG polyautoimmunity presents complex immunological mechanisms that require a multidisciplinary approach. Evidence-based comprehensive management that integrates immunomodulatory therapy, treatment of VAP complications, high-protein enteral nutrition, mobilization, and progressive pulmonary rehabilitation significantly improved respiratory function and accelerated weaning from the ventilator. Conclusion: An evidence-based, comprehensive approach through multidisciplinary collaboration can enhance ventilator weaning and improve clinical outcomes and quality of life in patients with MS-MG polyautoimmunity.
References
Basiri K, Etemadifar M, Maghzi A, Zarghami N. Frequency of myasthenia gravis in multiple sclerosis : Report of five cases from Isfahan, Iran. Neurology India [Internet]. 2009 Jan [cited 2025 Jul 22] 1;57(5):638. Available from: https://doi.org/10.4103/0028-3886.57817.
Isbister CM, Mackenzie PJ, Anderson D, Wade NK, Oger J. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Multiple Sclerosis Journal [Internet]. 2003 Nov 12 [cited 2025 Jul 22];9(6):550–3. Available from: https://doi.org/10.1191/1352458503ms964oa.
Dehbashi S, Hamouda D, Shanina E. Co-occurrence of multiple sclerosis and myasthenia gravis: A case report and review of immunological theories. Multiple Sclerosis and Related Disorders [Internet]. 2019 Jun 26 [cited 2025 Aug 2];34:135–6. Available from: https://doi.org/10.1016/j.msard.2019.06.027.
Rynkeviè G, Kizlaitienë R. Co-occurrence of myasthenia gravis and multiple sclerosis : a case report. Neurologijos Seminarai [Internet]. 2024 Feb 13 [cited 2025 Aug 2];27(96):101–6. Available from: https://doi.org/10.29014/ns.2023.27.13.
Sari DP, Kurniawan SN. Myasthenia gravis. Journal of Pain, Headache and Vertigo [Internet]. 2023 [cited 2025 Jul 23];4:16–9. Available from: https://doi.org/10.21776/ub.jphv.2023.004.01.4.
Sugiarto C, Sobaryati S, Sadeli HA, Murni TW. Perbandingan dosis piridostigmin, performa fungsional, dan derajat klinis pasien miastenia gravis sebelum dan setelah timektomi. Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia [Internet]. 2018 Sep 1 [cited 2025 Jul 23];35(4). Available from: https://doi.org/10.52386/neurona.v35i4.23.
Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N, et al. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. Journal of Neuroinflammation [Internet]. 2022 Apr 12 [cited 2025 Aug 2];19(1). Available from: https://doi.org/10.1186/s12974-022-02448-4.
Mazeraud A, Sivanandamoorthy S, Mancusi R, Clair B, Friedman D, Fadel F, et al. Weaning from mechanical ventilation during myasthenic crisis, a monocentric retrospective study. Scientific Reports [Internet]. 2024 Aug 22 [cited 2025 Aug 2];14(1). Available from: https://doi.org/10.1038/s41598-024-70373-y.
Ciotti JR, Cross AH. Disease-modifying treatment in progressive multiple sclerosis. Current Treatment Options in Neurology [Internet]. 2018 [cited 2025 Jul 22];20(12). Available from: https://doi.org/10.1007/s11940-018-0496-3.
Myllynen C, Tuulasvaara A, Atula S, Laakso SM. Intensive care due to myasthenia gravis : Risk factors and prognosis. European Journal of Neurology [Internet]. 2024 Oct 22 [cited 2025 Jul 22];31(12). Available from: https://doi.org/10.1111/ene.16522.
Tonev D, Momchilova A. Therapeutic plasma exchange and multiple sclerosis dysregulations: focus on the removal of pathogenic circulatory factors and altering nerve growth factor and Sphingosine-1-Phosphate plasma levels. Current Issues in Molecular Biology [Internet]. 2023 Sep 25 [cited 2025 Aug 8];45(10):7749–74. Available from: https://doi.org/10.3390/cimb45100489.
Setyawati T, Sujud RW, Indriasari I. Tata laksana ICU krisis miasthenia pada pasien tuberkulosis paru dengan penyulit ventilator associated pneumonia (VAP). Jurnal Anestesi Perioperatif [Internet]. 2020 Aug 1 [cited 2025 Aug 8];8(2):131–40. Available from: https://doi.org/10.15851/jap.v8n2.2052.
Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, et al. Guideline for the management of myasthenic syndromes. Therapeutic Advances in Neurological Disorders [Internet]. 2023 Jan 1 [cited 2025 Aug 8];16. Available from: https://doi.org/10.1177/17562864231213240.
Farrokhi M. Narrative review plasmapheresis for multiple sclerosis in the twenty-first century : Take it or leave it ?. Journal of Reviews in Medical Sciences [Internet]. 2021 [cited 2025 Aug 8];1(1):e1. Available from: https://doi.org/10.22034/jrms.2021.160046.
Ipe TS, Davis AR, Raval JS. Therapeutic plasma exchange in myasthenia gravis : A systematic literature review and meta-analysis of comparative evidence. Frontiers in Neurology [Internet]. 2021 [cited 2025 Aug 2];12:662856. Available from: https://doi.org/10.3389/fneur.2021.662856.
Zain A, Akram MS, Ashfaq F, Ans A, Ans HH. Comparative analysis of intravenous immunoglobulins ( IVIg ) vs plasmapheresis ( PLEX ) in the management of myasthenic crisis. Cureus [Internet]. 2024 Sep 7 [cited 2025 Jul 22];16(9):e68895. Available from: https://doi.org/10.7759/cureus.68895.
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated penumonia. American Journal Respiratory and Critical Care Medicine [Internet]. 2005 Feb 7 [cited 2025 Aug 8];171(4):388–416. Available from: https://doi.org/10.1164/rccm.200405-644st.
Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia : 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases [Internet]. 2016 Jul 14 [cited 2025 Aug 8];63(5):e61–111. Available from: https://doi.org/10.1093/cid/ciw353.
Roberts PR, Todd SR. Comprehensive Critical Care : Adult. 2022.
Su M, Jin S, Jiao K, Yan C, Song J, Xi J, et al. Pneumonia in myasthenia gravis : Microbial etiology and clinical management. Frontiers in Cellular and Infection Microbiology [Internet]. 2022 Dec 9 [cited 2025 Aug 8];12. Available from: https://doi.org/10.3389/fcimb.2022.1016728.
Mishima Y, Nawa N, Asada M, Nagashima M, Aiso Y, Nukui Y, et al. Impact of antibiotic time-outs in multidisciplinary ICU rounds for antimicrobial stewardship program on patient survival: A controlled before-and-after study. Critical Care Explorations [Internet]. 2023 Jan 1 [cited 2025 Aug 8];5(1):e0837. Available from: https://doi.org/10.1097/cce.0000000000000837.
Jang MH, Shin MJ, Shin YB. Pulmonary and physical rehabilitation in critically ill patients. Acute and Critical Care [Internet]. 2019 Feb 28 [cited 2025 Aug 8];34(1):1–13. Available from: https://doi.org/10.4266/acc.2019.00444.
Chauhan S, Aggarwal R, Behari M, Gupta C, Dua V. Effect of early mobility in mechanically ventilated patients with myasthenia crisis on duration of mechanical ventilation and length of intensive care unit stay. Physiotherapy - the Journal of Indian Association of Physiotherapists [Internet]. 2020 Jan 1 [cited 2025 Aug 8];14(2):74. Available from: https://doi.org/10.4103/pjiap.pjiap_40_20.
Al-Dorzi HM, AlQahtani S, Al-Dawood A, Al-Hameed FM, Burns KEA, Mehta S, et al. Association of early mobility with the incidence of deep ‑ vein thrombosis and mortality among critically ill patients : a post hoc analysis of PREVENT trial. Critical Care [Internet]. 2023 Mar 3 [cited 2025 Aug 8];27(1). Available from: https://doi.org/10.1186/s13054-023-04333-9.
Liu K, Tronstad O, Flaws D, Churchill L, Jones AYM, Nakamura K, et al. From bedside to recovery : exercise therapy for prevention of post ‑ intensive care syndrome. Journal of Intensive Care [Internet]. 2024 Feb 29 [cited 2025 Aug 8];12(1). Available from: https://doi.org/10.1186/s40560-024-00724-4.
Gual N, Gracia-Salmones M, Britez L, Crespo N, Udina C, Pérez LM, et al. The role of physical exercise and rehabilitation in delirium. European Geriatric Medicine [Internet]. 2020 Feb 1 [cited 2025 Aug 8];11(1):83–93. Available from: https://doi.org/10.1007/s41999-020-00290-6.
Zhou L, Xie F, Zeng Y, Xia X, Wang R, Cai Y, et al. Preventive effects of early mobilisation on delirium incidence in critically ill patients: systematic review and meta-analysis. Medizinische Klinik - Intensivmedizin Und Notfallmedizin [Internet]. 2025 Mar 14 [cited 2025 Aug 8]; Available from: https://doi.org/10.1007/s00063-024-01243-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Eva Octavia, Radian Ahmad Halimi, Nurita Dian Kestriani Saragi Sitio

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.











